Vaccine health study
- Health and wellness
- Open to the public
The CDC is partnering with ASU on a longitudinal study to investigate immune response of influenza and COVID-19 vaccines.
Vaccination: Participants will be randomly assigned an FDA approved influenza and COVID-19 vaccine that will be administered simultaneously or 28 days apart.
Blood draw: There will be a blood collection for every in- person visit to measure antibody waning.
Weekly follow-up survey: For surveillance purposes, participants will complete a brief survey to determine the presence of new flu-like symptoms.
Those who qualify: Healthy adults 18–64 that have not received the current season's influenza or COVID-19 vaccination in the past six months.
- Voluntary participation throughout the flu season
- Up to 6 visits
- Up to $200 compensation
Schedule an appointment here. For questions, contact email@example.com
View the flyer here.